Provided by Tiger Trade Technology Pte. Ltd.

Abbott Laboratories

114.10
-2.0300-1.75%
Post-market: 114.01-0.0900-0.08%17:15 EDT
Volume:6.96M
Turnover:798.54M
Market Cap:198.41B
PE:36.92
High:116.72
Open:115.40
Low:114.01
Close:116.13
52wk High:137.49
52wk Low:81.97
Shares:1.74B
Float Shares:1.70B
Volume Ratio:0.95
T/O Rate:0.41%
Dividend:2.48
Dividend Rate:2.17%
EPS(TTM):3.09
EPS(LYR):3.73
ROE:10.58%
ROA:5.33%
PB:3.88
PE(LYR):30.59

Loading ...

Abbott Laboratories Stock Underperforms Wednesday When Compared to Competitors

Dow Jones
·
45 mins ago

US Companies Face Rise in Cyber Attacks

Reuters
·
Yesterday

Piper Sandler Sticks to Their Buy Rating for Abbott Laboratories (ABT)

TIPRANKS
·
Yesterday

Perrigo Co. PLC Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Yesterday

Abbott Laboratories Gets Regulatory Authorization for Dual Glucose-Ketone Sensor

MT Newswires Live
·
Yesterday

FDA Authorizes Abbott's Wearable to Monitor Ketone and Glucose in Diabetes Patients

Reuters
·
Yesterday

Abbott receives FDA authorization for Libre Duo 10 Day system

TIPRANKS
·
Yesterday

Abbott - to Launch Libre Duo 10 Day in U.S. Later This Year

THOMSON REUTERS
·
Yesterday

Abbott Receives FDA Authorization for World's First Dual Glucose-Ketone Sensing Technology for People with Diabetes

THOMSON REUTERS
·
Yesterday

FDA Authorizes First Wearable Device That Continuously Monitors Both Ketone Levels and Blood Sugar

Reuters
·
Yesterday

FDA :Granted Marketing Authorization to Abbott Diabetes Care for Libre Duo 10 Day Through De Novo Premarket Review Pathway

THOMSON REUTERS
·
Yesterday

Abbott Laboratories Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Aug 22

Analyst Raises Abbott Price Target to $135 on Strengthening Cancer Diagnostics Growth and Successful Exact Sciences Integration

TIPRANKS
·
Aug 21

Dow Jones Top Company Headlines at 9 am ET: Nvidia in Talks to Invest in Data-Center Power Developer Cloverleaf | Italy's ...

Dow Jones
·
Aug 21

Analysts Offer Insights on Healthcare Companies: Corcept Therapeutics (CORT), Alvotech (ALVO) and Abbott Laboratories (ABT)

TIPRANKS
·
Aug 21

Wells Fargo Keeps Their Buy Rating on Abbott Laboratories (ABT)

TIPRANKS
·
Aug 21

TD Cowen Adjusts Price Target on Abbott Laboratories to $135 From $115, Maintains Buy Rating

MT Newswires Live
·
Aug 21

Analysts Have Conflicting Sentiments on These Healthcare Companies: Abbott Laboratories (ABT) and Doximity (DOCS)

TIPRANKS
·
Aug 21

U.S. Research Roundup-Health Catalyst, Nektar Therapeutics, TIC Solutions

Reuters
·
Aug 21

PRESS Digest-Wall Street Journal - August 21

Reuters
·
Aug 21